Table 2.
Study | Patients, n | Extrahepatic disease | Preoperative chemotherapy, % | Response ratea, % | Synchronous colorectal resection, % | Liver resection, % | Ablation, % | Operative portal vein ligation/embolization, % | Postoperative morbidity, % | Postoperative mortality, % |
---|---|---|---|---|---|---|---|---|---|---|
Turrini et al.25 | 48 | No | 100 | NR | 37 | 87 | 67 | 0 | 10 | 0 |
Tsim et al.26 | 38 | No | 97 | NR | 0 | 100 | 0 | 0 | 11 | 0 |
Narita et al.27 | 80 | Yes | 84 | 100 | 40 | 99 | 31 | 4 | 14 | 0 |
Muratore et al.24 | 47 | Yes | 79 | 92 | 50 | 100 | 0 | 23 | 19 | 0 |
Brouquet et al.23 | 65 | No | 100 | 100 | 29 | 100 | 3 | 0 | 25 | 0 |
Bowers et al.22 | 39b | Yes | 74 | NR | 31 | 100 | 8 | 0 | 23 | 0 |
Tsai et al.21 | 45 | Yes | 71 | NR | 50 | 91 | 29 | 73 | 26 | 4c |
Wicherts et al.20 | 59 | Yes | 97 | 100 | 20 | 100 | 5 | 56 | 20 | 0 |
Pamecha et al.19 | 14 | No | 100 | 79 | NR | 100 | 0 | 0 | 0 | 0 |
Tanaka et al.18 | 24 | No | 64 | NR | NR | 100 | 0 | 71 | 13 | 0 |
Total | 459 | 88 | 97 | 35 | 98 | 17 | 20 | 17 | ||
Range | 64–100 | 79–100 | 0–50 | 87–100 | 0–67 | 4–71 | 0–26 |
Includes partial or stable radiological response to chemotherapy.
Series included patients with liver metastases from colorectal cancer (n = 33), neuroendocrine tumours (n = 3), gastrointestinal stromal tumour (n = 1), ocular melanoma (n = 1) and salivary gland carcinoma (n = 1).
Two postoperative deaths: one from liver insufficiency and one from pulmonary embolus.
NR, not reported.